• home
  • partners
  • contact
  • Uitgaven
  • partners
  • Vacatures
  • Nieuws
  • Agenda
  • Opleidingen
    • Nucleair Radioloog
    • Klinisch fysicus
    • Medisch nucleair werker
    • Ziekenhuisapotheker
    • Radiochemicus
  • Adverteren
  • Redactie
home > Uitgaven > Jun '23. Palliative radionuclide therapy for bone metastases with strontium-89-chloride and samarium

Jun '23. Palliative radionuclide therapy for bone metastases with strontium-89-chloride and samarium

Auteur

K. Chung, J.M.H. de Klerk

Vakblad

TvNG

Editie

2023-02, juni

Thema

Radionuclidentherapie


 

Download nu

De PDF wordt automatisch gedownload. Afhankelijk van uw browser of device opent deze zich automatisch of staat in de downloads van uw browser

  • Inhoudsopgave

A considerable proportion of patients with cancer will develop bone metastases. Bone metastases frequently cause severe bone pain and seriously affect quality of life. Palliative treatment of patients with bone pain from multiple bone metastases using radiopharmaceuticals such as [89Sr]SrCl2 and [153Sm]Sm-EDMTP can be a safe and easily accessible option to effectively relieve bone pain.

Hoofdpartner

Business partners

  • Copyright
  • Algemene voorwaarden
  • Disclaimer
  • Privacy
  • Sitemap
  • Colofon

© Kloosterhof Neer BV